Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KORLYM® safely and effectively. See full prescribing information for KORLYM®. KORLYM® (mifepristone) 300 mg Tablets Initial U.S. Approval 2000
Medication labelWhy this: Advisory · dailymed-prescription
KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. LIMITATIONS OF USE: KORLYM should not be used in the treatment of patients with type 2 diabetes unless it is secondary to Cushing's syndrome.
- generic_name
- mifepristone
- product_names
- Mifepristone
- ndc
- 76346-073, 76346-073-01, 76346-073-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en